Wuhan Dazhong Dental Medical Co., Ltd. published a detailed document outlining the establishment and guidelines of its Nomination Committee. The document clarifies its scope in regulating the appointment of directors and senior management, optimizing Board composition, and enhancing corporate governance.

The Nomination Committee comprises at least three directors, with a majority serving as independent non-executive directors. The chair of the committee can be the Board chair or an independent non-executive director. Terms of service match the Board’s duration, and the committee is empowered to recommend qualified director and senior management candidates for the Board’s review.

Key responsibilities include formulating selection criteria and procedures, maintaining a talent pool for senior positions, assessing the independence of independent directors, and advising on Board structure and composition. The committee is required to review director nominees’ professional and educational backgrounds in line with regulatory rules, and it may engage external agencies to assist in identifying qualified candidates.

The committee reports to the Board, and any nominations for director positions must be submitted for final shareholder approval. The announcement also describes a recusal system for committee members who face conflicts of interest. As stated, all meetings must adhere to transparency and confidentiality requirements, with decisions documented in meeting minutes and reported to the Board. The Terms of Reference are disclosed on both the Hong Kong Stock Exchange and the company’s official website.